NXTCNextCure, Inc. insider trades
In the last 90 days, 1 insider bought $53.7K of NextCure, Inc. (NXTC) on the open market and none sold. The largest purchase was $27.2K by ADAR1 Capital Management, LLC on Oct 23.
- Market cap
- $26.16M
- as of 2026-10-27
- Latest close
- $5.72
- as of 2026-10-27
- Sector
- Healthcare
- as of 2026-10-27
- Industry
- Biotechnology
- as of 2026-10-27
Cluster
No cluster in the last 90 days under the default rule (14d · ≥2 insiders · all roles).
Form 4 historysince 2024-02-01
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| ADAR1 Capital Management, LLC | Oct 27 | Oct 27 | P | 3,553 | $5.10 | Purchase +$18,104 | 733,270 | No | Form 4 |
| ADAR1 Capital Management, LLC | Oct 26 | Oct 27 | P | 1,672 | $5.03 | Purchase +$8,418 | 729,717 | No | Form 4 |
| ADAR1 Capital Management, LLC | Oct 23 | Oct 27 | P | 5,626 | $4.83 | Purchase +$27,170 | 728,045 | No | Form 4 |
| Jiangsu Simcere Zaiming Pharmaceutical Co., Ltd. | Aug 10 | Aug 12 | S | 30,000 | $6.16 | Sale −$184,800 | 308,636 | No | Form 4 |
| ADAR1 Capital Management, LLC | Jul 31 | Aug 3 | P | 3,300 | $4.98 | Purchase +$16,434 | 689,416 | No | Form 4 |
| ADAR1 Capital Management, LLC | Jul 31 | Aug 3 | P | 25,000 | $4.98 | Purchase +$124,500 | 714,416 | No | Form 4 |
| ADAR1 Capital Management, LLC | Jul 31 | Aug 3 | P | 8,003 | $4.80 | Purchase +$38,414 | 722,419 | No | Form 4 |
| ADAR1 Capital Management, LLC | Jul 30 | Aug 3 | P | 50,000 | $4.97 | Purchase +$248,500 | 443,266 | No | Form 4 |
| ADAR1 Capital Management, LLC | Jul 30 | Aug 3 | P | 20,000 | $5.00 | Purchase +$100,000 | 463,266 | No | Form 4 |
| ADAR1 Capital Management, LLC | Jul 30 | Aug 3 | P | 20,000 | $5.00 | Purchase +$100,000 | 483,266 | No | Form 4 |
| ADAR1 Capital Management, LLC | Jul 30 | Aug 3 | P | 25,000 | $4.81 | Purchase +$120,250 | 508,266 | No | Form 4 |
| ADAR1 Capital Management, LLC | Jul 30 | Aug 3 | P | 100,000 | $4.90 | Purchase +$490,000 | 608,266 | No | Form 4 |
| ADAR1 Capital Management, LLC | Jul 30 | Aug 3 | P | 77,850 | $4.96 | Purchase +$386,136 | 686,116 | No | Form 4 |
| ADAR1 Capital Management, LLC | Jul 29 | Jul 29 | P | 1,810 | $5.00 | Purchase +$9,050 | 391,666 | No | Form 4 |
| ADAR1 Capital Management, LLC | Jul 29 | Jul 29 | P | 1,600 | $5.00 | Purchase +$8,000 | 393,266 | No | Form 4 |
| ADAR1 Capital Management, LLC | Jul 28 | Jul 29 | P | 6,400 | $4.95 | Purchase +$31,680 | 389,856 | No | Form 4 |
| ADAR1 Capital Management, LLC | Jul 27 | Jul 29 | P | 7,798 | $5.00 | Purchase +$38,990 | 383,456 | No | Form 4 |
| Webster Stephen W | Jun 18 | Jun 22 | A · derivative | 2,340 | $2.02 | $4,727 | 2,340 | No | Form 4 |
| Kabakoff David S | Jun 18 | Jun 22 | A · derivative | 3,510 | $2.02 | $7,090 | 3,510 | No | Form 4 |
| Jones Elaine V | Jun 18 | Jun 22 | A · derivative | 2,340 | $2.02 | $4,727 | 2,340 | No | Form 4 |
| Houston John G | Jun 18 | Jun 22 | A · derivative | 2,340 | $2.02 | $4,727 | 2,340 | No | Form 4 |
| Feigal Ellen | Jun 18 | Jun 22 | A · derivative | 2,340 | $2.02 | $4,727 | 2,340 | No | Form 4 |
| Borgman Anne Elizabeth | Jun 18 | Jun 22 | A · derivative | 2,340 | $2.02 | $4,727 | 2,340 | No | Form 4 |
| Cobourn Steven P.Chief Financial Officer | Jan 30 | Feb 3 | A · derivative | 14,670 | $10.85 | $159,170 | 14,670 | No | Form 4 |
| Guha UdayanChief Medical Officer | Jan 30 | Feb 3 | A · derivative | 14,670 | $10.85 | $159,170 | 14,670 | No | Form 4 |
| Mayer TimothyChief Operating Officer | Jan 30 | Feb 3 | A · derivative | 14,670 | $10.85 | $159,170 | 14,670 | No | Form 4 |
| Kundu SouravSr VP, Dev. & Mfg. | Jan 30 | Feb 3 | A · derivative | 8,270 | $10.85 | $89,730 | 8,270 | No | Form 4 |
| Richman MichaelPresident & CEO | Jan 30 | Feb 3 | A · derivative | 38,190 | $10.85 | $414,362 | 38,190 | No | Form 4 |
| Shaw Kevin G.Sr VP, General Counsel | Jan 30 | Feb 3 | A · derivative | 8,270 | $10.85 | $89,730 | 8,270 | No | Form 4 |
| Feigal Ellen | Jun 20, 2025 | Jun 24, 2025 | A · derivative | 18,700 | $0.47 | $8,789 | 18,700 | No | Form 4 |
| Webster Stephen W | Jun 20, 2025 | Jun 24, 2025 | A · derivative | 18,700 | $0.47 | $8,789 | 18,700 | No | Form 4 |
| Borgman Anne Elizabeth | Jun 20, 2025 | Jun 24, 2025 | A · derivative | 18,700 | $0.47 | $8,789 | 18,700 | No | Form 4 |
| Kabakoff David S | Jun 20, 2025 | Jun 24, 2025 | A · derivative | 28,050 | $0.47 | $13,184 | 28,050 | No | Form 4 |
| Jones Elaine V | Jun 20, 2025 | Jun 24, 2025 | A · derivative | 18,700 | $0.47 | $8,789 | 18,700 | No | Form 4 |
| Houston John G | Jun 20, 2025 | Jun 24, 2025 | A · derivative | 18,700 | $0.47 | $8,789 | 18,700 | No | Form 4 |
| Richman MichaelPresident & CEO | Jan 31, 2025 | Feb 3, 2025 | A · derivative | 305,500 | $0.80 | $244,400 | 305,500 | No | Form 4 |
| Cobourn Steven P.Chief Financial Officer | Jan 31, 2025 | Feb 3, 2025 | A · derivative | 117,375 | $0.80 | $93,900 | 117,375 | No | Form 4 |
| Kundu SouravSr VP, Dev. & Mfg. | Jan 31, 2025 | Feb 3, 2025 | A · derivative | 66,125 | $0.80 | $52,900 | 66,125 | No | Form 4 |
| Langermann SolChief Scientific Officer | Jan 31, 2025 | Feb 3, 2025 | A · derivative | 117,375 | $0.80 | $93,900 | 117,375 | No | Form 4 |
| Mayer TimothyChief Operating Officer | Jan 31, 2025 | Feb 3, 2025 | A · derivative | 117,375 | $0.80 | $93,900 | 117,375 | No | Form 4 |
| Shaw Kevin G.Sr VP, General Counsel | Jan 31, 2025 | Feb 3, 2025 | A · derivative | 66,125 | $0.80 | $52,900 | 66,125 | No | Form 4 |
| Borgman Anne Elizabeth | Jun 20, 2024 | Jun 21, 2024 | A · derivative | 18,700 | $1.50 | $28,050 | 18,700 | No | Form 4 |
| Feigal Ellen | Jun 20, 2024 | Jun 21, 2024 | A · derivative | 18,700 | $1.50 | $28,050 | 18,700 | No | Form 4 |
| Houston John G | Jun 20, 2024 | Jun 21, 2024 | A · derivative | 18,700 | $1.50 | $28,050 | 18,700 | No | Form 4 |
| Jones Elaine V | Jun 20, 2024 | Jun 21, 2024 | A · derivative | 18,700 | $1.50 | $28,050 | 18,700 | No | Form 4 |
| Kabakoff David S | Jun 20, 2024 | Jun 21, 2024 | A · derivative | 28,050 | $1.50 | $42,075 | 28,050 | No | Form 4 |
| Webster Stephen W | Jun 20, 2024 | Jun 21, 2024 | A · derivative | 18,700 | $1.50 | $28,050 | 18,700 | No | Form 4 |
| Cobourn Steven P.Chief Financial Officer | Mar 29, 2024 | Apr 2, 2024 | A · derivative | 93,900 | $2.23 | $209,397 | 93,900 | No | Form 4 |
| Kundu SouravSr VP, Dev. & Mfg. | Mar 29, 2024 | Apr 2, 2024 | A · derivative | 52,900 | $2.23 | $117,967 | 52,900 | No | Form 4 |
| Langermann SolChief Scientific Officer | Mar 29, 2024 | Apr 2, 2024 | A · derivative | 93,900 | $2.23 | $209,397 | 93,900 | No | Form 4 |
| Mayer TimothyChief Operating Officer | Mar 29, 2024 | Apr 2, 2024 | A · derivative | 93,900 | $2.23 | $209,397 | 93,900 | No | Form 4 |
| Myint HanChief Medical Officer | Mar 29, 2024 | Apr 2, 2024 | A · derivative | 93,900 | $2.23 | $209,397 | 93,900 | No | Form 4 |
| Richman MichaelPresident & CEO | Mar 29, 2024 | Apr 2, 2024 | A · derivative | 244,400 | $2.23 | $545,012 | 244,400 | No | Form 4 |
| Shaw Kevin G.Sr VP, General Counsel | Mar 29, 2024 | Apr 2, 2024 | A · derivative | 93,900 | $2.23 | $209,397 | 93,900 | No | Form 4 |
| Cobourn Steven P.Chief Financial Officer | Jan 31, 2024 | Feb 1, 2024 | A · derivative | 117,375 | $1.22 | $143,198 | 117,375 | No | Form 4 |
| Kundu SouravSr VP, Dev. & Mfg. | Jan 31, 2024 | Feb 1, 2024 | A · derivative | 66,125 | $1.22 | $80,673 | 66,125 | No | Form 4 |
| Langermann SolChief Scientific Officer | Jan 31, 2024 | Feb 1, 2024 | A · derivative | 117,375 | $1.22 | $143,198 | 117,375 | No | Form 4 |
| Mayer TimothyChief Operating Officer | Jan 31, 2024 | Feb 1, 2024 | A · derivative | 117,375 | $1.22 | $143,198 | 117,375 | No | Form 4 |
| Myint HanChief Medical Officer | Jan 31, 2024 | Feb 1, 2024 | A · derivative | 117,375 | $1.22 | $143,198 | 117,375 | No | Form 4 |
| Richman MichaelPresident & CEO | Jan 31, 2024 | Feb 1, 2024 | A · derivative | 305,500 | $1.22 | $372,710 | 305,500 | No | Form 4 |
| Shaw Kevin G.Sr VP, General Counsel | Jan 31, 2024 | Feb 1, 2024 | A · derivative | 66,125 | $1.22 | $80,673 | 66,125 | No | Form 4 |